Greenwood Capital Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$923K Buy
14,657
+2,373
+19% +$166K 0.09% 166
2026
Q1
$927K Sell
12,284
-10,596
-46% -$756K 0.1% 153
2025
Q4
$1.41M Buy
22,880
+1,083
+5% +$63.7K 0.15% 124
2025
Q3
$1.28M Buy
+21,797
New +$1.27M 0.15% 128
2023
Q1
Sell
-72,917
Closed -$5.33M 250
2022
Q4
$5.33M Sell
72,917
-1,499
-2% -$118K 0.87% 44
2022
Q3
$6.21M Sell
74,416
-640
-0.9% -$55.1K 1.07% 33
2022
Q2
$5.98M Sell
75,056
-720
-1% -$69.9K 0.96% 38
2022
Q1
$7.88M Sell
75,776
-21,857
-22% -$1.81M 2.07% 17
2021
Q4
$7.34M Sell
97,633
-5,228
-5% -$366K 1.04% 39
2021
Q3
$6.67M Sell
102,861
-20,828
-17% -$1.27M 1.02% 41
2021
Q2
$7.5M Buy
123,689
+3,658
+3% +$216K 1.13% 34
2021
Q1
$6.47M Buy
120,031
+37,853
+46% +$2.06M 1.02% 32
2020
Q4
$3.96M Buy
+82,178
New +$3.63M 0.67% 53

Other funds holding NTR

Greenwood Capital Associates's NTR Position: Q2 2026 in Review

Greenwood Capital Associates increased its Nutrien (NTR) stake by 19% in Q2 2026, buying an estimated $166K and bringing the position to 14,657 shares worth $923K. The position accounts for 0.09% of the portfolio, ranked #166.

Greenwood Capital Associates first reported a position in NTR in Q4 2020 and has held it in 13 quarters since. The position peaked at $7.88M in Q1 2022. 196 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Greenwood Capital Associates held 14,657 shares of Nutrien worth $923K as of Q2 2026.
  • Greenwood Capital Associates bought 2,373 Nutrien shares in Q2 2026, an estimated $166K.
  • Nutrien made up 0.09% of Greenwood Capital Associates's portfolio in Q2 2026, its #166 holding.
  • Greenwood Capital Associates first reported a position in Nutrien in Q4 2020 and has held it in 13 quarters since.
  • Greenwood Capital Associates's Nutrien position peaked at $7.88M in Q1 2022.
  • 196 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Greenwood Capital Associates's 13F filing for Q2 2026, filed 28 Jul 2026.